Back to results
US 2025/0026750 A1Published application
Sulfoximine-containing atr inhibitor compound
AssigneeChia Tai Tianqing Pharmaceutical Group Co., Ltd.
InventorsYinsheng ZHANG, Yan ZHU, Baomin LIU, Kuo GAI, Shawei CHEN, Wei SHI
Life of this patent
Estimating the term…
Abstract
A sulfoximine-containing ATR inhibitor compound as represented by formula (I), a preparation method therefor, a pharmaceutical composition containing same, and the use thereof in the treatment of ATR-related or ATR-mediated diseases and/or conditions.
Claims20
A compound of formula (I), a stereoisomer thereof or a pharmaceutically acceptable salt thereof,
- wherein
- is a double bond, X is selected from CRa, and Y is selected from N;
- or, is a single bond, X is selected from C═O, and Y is selected from NRb;
- Ra is selected from the group consisting of hydrogen, hydroxy, cyano, halogen, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C3-10 cycloalkyl, 3-10 membered heterocycloalkyl and C3-10 cycloalkyl-C2-6 alkynyl, wherein the C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C3-10 cycloalkyl, 3-10 membered heterocycloalkyl and C3-10 cycloalkyl-C2-6 alkynyl are optionally substituted with one or more halogen, hydroxy or cyano substituents;
- Rb is selected from the group consisting of hydrogen and C1-6 alkyl;
- R1 and R2 are each independently selected from the group consisting of C1-10 alkyl, C3-10 cycloalkyl, 3-10 membered heterocycloalkyl, C6-10 membered aryl and 5-10 membered heteroaryl, wherein the C3-10 cycloalkyl, 3-10 membered heterocycloalkyl, C6-10 membered aryl and 5-10 membered heteroaryl are optionally substituted with one or more Rc;
- or R1 and R2, together with the sulfur atom to which they are attached, form 3-10 membered heterocyclyl, and the 3-10 membered heterocyclyl is optionally substituted with one or more Rd;
- Rc and Rd are each independently selected from the group consisting of halogen, hydroxy, amino, C1-6 alkyl, C1-6 alkoxy, C1-6 alkyl-C(O)—, C1-6 alkyl-S(O)2—, C3-10 cycloalkyl, 3-10 membered heterocycloalkyl, C6-10 membered aryl and 5-10 membered heteroaryl;
- R3 is selected from 5-10 membered heteroaryl optionally substituted with one or more Re;
- Re is selected from the group consisting of hydroxy, amino, halogen, C1-6 alkyl, C1-3 haloalkyl, C3-6 cycloalkyl and 3-6 membered heterocycloalkyl.
7 more elements
(canceled)
Dependencies are inferred from the claim text.